Journal of Neurophysiology, Vol 76, Issue 5 3025-3037, Copyright © 1996 by APS

ARTICLES

Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation

K. Ren and R. Dubner
Department of Oral and Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore 21201, USA.

1. The role of descending brain stem modulatory systems in the development of persistent behavioral hyperalgesia and dorsal horn hyperexcitability was studied in rats with unilateral hindpaw inflammation. Inflammation was induced by intraplantar injection of complete Freund's adjuvant (CFA, 0.05 ml of an 1:1 oil/saline emulsion, 25 micrograms Mycobacterium), or lambda carrageenan (1 mg/ 0.1 ml saline). Thermal hyperalgesia was assessed by testing paw withdrawal latency (PWL) to a noxious heat stimulus. Superficial dorsal horn nociceptive (nociceptive specific, NS, and wide dynamic range, WDR) neuronal activity in the lumbar spinal cord was recorded extracellularly in chloralose-anesthetized rats. 2. Bilateral lesions of the dorsolateral funiculus (DLFX) at the T10 level were made in 13 rats, and the development of thermal hyperalgesia in these rats was compared with sham-operated or nonoperated control rats. In rats receiving a 0.05-ml CFA injection, a similar magnitude of hyperalgesia developed in the inflamed paw in DLFX (n = 7) and control (n = 8) rats. In addition, there appeared to be a contralateral hyperalgesia that was most apparent between 2 and 24 h after injection of CFA in DLFX rats. The CFA-induced contralateral effects were significantly different (P < 0.05) from the control rats at 2 and 6 h. 3. The intensity of the thermal stimulus was reduced and a low dose of carrageenan (1 mg) was injected into one hindpaw to further reveal the potentiation of hyperalgesia in DLFX rats. Throughout the 0.5- to 4-h time period after the injection of carrageenan, the PWL of the inflamed paws in DLFX rats (n = 6) was significantly shorter than that of control rats (n = 10; 2-way analysis of variance, F1,14 = 14.04, P < 0.01), suggesting the enhancement of hyperalgesia in DLFX rats. A hyperalgesia on the noninflamed paws was also more apparent in this experiment in DLFX rats, when compared with control rats. DLFX did not affect the baseline PWL of the rats. 4. A reversible spinalization was produced by application of a local anesthetic, lidocaine (2%, 0.1 ml), onto the dorsal surface of the thoracic cord (T10-12). This procedure produced thoracic spinal block that lasted for 90 min. The effects of thoracic lidocaine block on nociceptive neuronal activity were studied in 11 neurons (NS = 7, WDR = 4) in CFA-inflamed rats and 10 neurons (NS = 6, WDR = 4) in noninflamed naive rats. After the thoracic lidocaine block, rats showed increases in background activity, expansion of the receptive fields, and increased responses to noxious thermal, mechanical, and electrical stimuli. 5. Quantitative comparison revealed that the mean change in background firing rate of dorsal horn neurons was greater in inflamed [NS: 18.3 +/- 0.4 Hz, (mean +/- SE) n = 7; WDR: 10.9 +/- 0.7 Hz, n = 4] than that in noninflamed (NS: 2.3 +/- 0.3 Hz, n = 6; WDR: 3.3 +/- 0.4 Hz, n = 4) rats (P < 0.01, t-test) after thoracic lidocaine block. Thoracic saline application produced a 2.8 +/- 0.4 Hz decrease in background activity (2 NS and 2 WDR units). The expansion of the receptive fields after thoracic lidocaine block was also greater in inflamed (NS: 141 +/- 9% control, n = 6; WDR: 240 +/- 36% control, n = 4) than in noninflamed (NS: 114 +/- 9% control, n = 6; WDR: 167 +/- 21% control, n = 4) rats (P < 0.05, t-test). Thoracic saline did not produce a significant change in the receptive field size (105 +/- 9%, n = 4). The increases in responses to noxious thermal and mechanical stimuli after thoracic lidocaine block were also significantly greater in inflamed than in noninflamed rats (P < 0.01). There was no significant difference in the increase in responses to electrical stimulation of the sciatic nerve after lidocaine between inflamed and noninflamed rats.(ASTRACT TRUNCATED)

This article has been cited by other articles:

				D. Budai, S. G. Khasabov, P. W. Mantyh, and D. A. Simone NK-1 Receptors Modulate the Excitability of ON Cells in the Rostral Ventromedial Medulla J Neurophysiol, February 1, 2007; 97(2): 1388 - 1395. [Abstract] [Full Text] [PDF]

				A. Miranda, S. Peles, R. Shaker, C. Rudolph, and J. N. Sengupta Neonatal nociceptive somatic stimulation differentially modifies the activity of spinal neurons in rats and results in altered somatic and visceral sensation J. Physiol., May 1, 2006; 572(3): 775 - 787. [Abstract] [Full Text] [PDF]

				J. Kitagawa, K. Kanda, M. Sugiura, Y. Tsuboi, A. Ogawa, K. Shimizu, N. Koyama, H. Kamo, T. Watanabe, K. Ren, et al. Effect of Chronic Inflammation on Dorsal Horn Nociceptive Neurons in Aged Rats J Neurophysiol, June 1, 2005; 93(6): 3594 - 3604. [Abstract] [Full Text] [PDF]

				K. Miki, Q.-Q. Zhou, W. Guo, Y. Guan, R. Terayama, R. Dubner, and K. Ren Changes in Gene Expression and Neuronal Phenotype in Brain Stem Pain Modulatory Circuitry After Inflammation J Neurophysiol, February 1, 2002; 87(2): 750 - 760. [Abstract] [Full Text] [PDF]

				Y. Guan, R. Terayama, R. Dubner, and K. Ren Plasticity in Excitatory Amino Acid Receptor-Mediated Descending Pain Modulation after Inflammation J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 513 - 520. [Abstract] [Full Text] [PDF]

				R. W. Hurley and D. L. Hammond Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal {micro} Opioid Receptor Agonists after Inflammatory Injury J. Neurosci., April 1, 2001; 21(7): 2536 - 2545. [Abstract] [Full Text] [PDF]

				H. Bester, C. De Felipe, and S. P. Hunt The NK1 Receptor Is Essential for the Full Expression of Noxious Inhibitory Controls in the Mouse J. Neurosci., February 1, 2001; 21(3): 1039 - 1046. [Abstract] [Full Text] [PDF]

				R. W. Hurley and D. L. Hammond The Analgesic Effects of Supraspinal {micro} and delta Opioid Receptor Agonists Are Potentiated during Persistent Inflammation J. Neurosci., February 1, 2000; 20(3): 1249 - 1259. [Abstract] [Full Text] [PDF]

				M. O. Urban and G. F. Gebhart Supraspinal contributions to hyperalgesia PNAS, July 6, 1999; 96(14): 7687 - 7692. [Abstract] [Full Text] [PDF]

				N. Danziger, J. Weil-Fugazza, D. Le Bars, and D. Bouhassira Alteration of Descending Modulation of Nociception during the Course of Monoarthritis in the Rat J. Neurosci., March 15, 1999; 19(6): 2394 - 2400. [Abstract] [Full Text] [PDF]

				C. Roza, J. M. A. Laird, and F. Cervero Spinal Mechanisms Underlying Persistent Pain and Referred Hyperalgesia in Rats With an Experimental Ureteric Stone J Neurophysiol, April 1, 1998; 79(4): 1603 - 1612. [Abstract] [Full Text] [PDF]

				R. Burstein, H. Yamamura, A. Malick, and A. M. Strassman Chemical Stimulation of the Intracranial Dura Induces Enhanced Responses to Facial Stimulation in Brain Stem Trigeminal Neurons J Neurophysiol, February 1, 1998; 79(2): 964 - 982. [Abstract] [Full Text] [PDF]

				M. S. Nadal, Y. Amarillo, E. Vega-Saenz de Miera, and B. Rudy Evidence for the presence of a novel Kv4-mediated A-type K+ channel-modifying factor J. Physiol., December 12, 2001; 537(3): 801 - 809. [Abstract] [Full Text] [PDF]